drugset / Trial / NCT00004083

Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer

NCT00004083 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of liposomal cisplatin in treating patients who have recurrent ovarian cancer.

Timeline

Start
1999-02
Primary completion
1999-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — Intravenous

Indications